Variant position: 45 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 365 The length of the canonical sequence.
Location on the sequence:
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human DKECGQLLISENQKVAAHHK CMLFSSALVSSHSDNESLGGF
Mouse DKECGQLLISENQKVAAHHK CMLFSSALVSSHSDNESLGGF
Bovine DKECGQLLISENQKVAAHHK CMLFSSALVSSHSDNESLGGF
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
2 – 365 PHD finger protein 6
14 – 52 C2HC pre-PHD-type 1
14 – 132 Extended PHD1 domain (ePHD1)
Mutations in PHF6 are associated with Boerjeson-Forssman-Lehmann syndrome.
Lower K.M.; Turner G.; Kerr B.A.; Mathews K.D.; Shaw M.A.; Gedeon A.K.; Schelley S.; Hoyme H.E.; White S.M.; Delatycki M.B.; Lampe A.K.; Clayton-Smith J.; Stewart H.; van Ravenswaay C.M.A.; de Vries B.B.A.; Cox B.; Grompe M.; Ross S.; Thomas P.; Mulley J.C.; Gecz J.;
Nat. Genet. 32:661-665(2002)
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1); TISSUE SPECIFICITY; SUBCELLULAR LOCATION; ALTERNATIVE SPLICING; VARIANTS BFLS TYR-45; PHE-99; ARG-229; GLU-234 AND GLY-257;
PHF6 regulates cell cycle progression by suppressing ribosomal RNA synthesis.
Wang J.; Leung J.W.; Gong Z.; Feng L.; Shi X.; Chen J.;
J. Biol. Chem. 288:3174-3183(2013)
Cited for: FUNCTION; SUBCELLULAR LOCATION; INTERACTION WITH UBTF; CHARACTERIZATION OF VARIANTS BFLS TYR-45 AND PHE-99;
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.